Daiichi Sankyo Company, Limited's (TSE:4568) P/E Is On The Mark - simplywall.st
  At ASCO 2025, attendees see reason for hope, despite worries - STAT
  Daiichi Sankyo Appoints Hiroyuki Okuzawa as Chief Executive Officer - Business Wire
  Merck, Daiichi Sankyo Pull Lung Cancer Filing for ADC, Citing Underwhelming Survival Findings - BioSpace
  Daiichi Sankyo struck gold with ‘ADC’ cancer drugs. Its new CEO has to figure out what’s next. - BioPharma Dive
  Daiichi Sankyo is leveraging Azure OpenAI Service to develop generative AI and foster an AI-friendly culture - Microsoft
  Daiichi Sankyo and Merck Pull Back Patritumab Deruxtecan BLA Based on Phase III HERTHENA-Lung02 Outcomes - Applied Clinical Trials
  Daiichi Sankyo Continues to Transform Treatment Landscape for Patients with Cancer with Practice-Changing Data at ASCO - Yahoo Finance